The Filing Desk

Amphstar Pharmaceuticals vs OPKO Health

Amphstar Pharmaceuticals AMPH · OPKO Health OPK · Pharmaceuticals

Amphstar Pharmaceuticals reported revenue of $720 million in fiscal 2025, 1.2 times OPKO Health's $607 million in fiscal 2025. Amphstar Pharmaceuticals' revenue fell 1.6% in its latest year, and OPKO Health's fell 14.9%. Amphstar Pharmaceuticals had an operating margin of 19.5%, against -19.4% at OPKO Health. Free cash flow was $121 million at Amphstar Pharmaceuticals and −$191 million at OPKO Health.

Side by side

Amphstar PharmaceuticalsOPKO Health
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$720M$607M
Revenue growth−1.6%−14.9%
Revenue growth a year, last 5 years15.5%−15.8%
Gross margin49.5%33.9%
Operating margin19.5%−19.4%
Net margin13.6%−37.2%
Free cash flow$121M−$191M
Free cash flow margin16.8%−31.4%
Return on capital9.9%−7.0%
Net debt to EBITDA1.7x—
Dividends and buybacks$76M$47M
Change in diluted share count−7.4%8.2%
Last close$29.37$1.68
P/E at the last close13.4×—
Insider trades, last 12 monthssold $2.1 million—
Piotroski F-score6 of 94 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
Amphstar PharmaceuticalsOPKO Health
Operating margin
Percent of revenue
Amphstar PharmaceuticalsOPKO Health
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Amphstar PharmaceuticalsOPKO Health

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Amphstar Pharmaceuticals and OPKO Health pages.